This Will Be Microsoft's Price Next Year

Microsoft trades at $370.87 with a 24/7 Wall St. price target of $488.47, implying 31.71% upside and a BUY recommendation. Q2 FY2026 EPS beat estimates by 7.57% at $4.14 versus $3.85, revenue rose 16.72% to $81.27 billion, and Azure grew 39% YoY with a $625 billion commercial RPO backlog. Despite the stock being below its 50-day and 200-day moving averages, the article argues AI/Copilot monetization and Azure momentum support further upside.

Analysis

MSFT is being priced like a mature mega-cap, but the business is behaving like an earlier-stage platform with a multi-year demand pipeline. The key second-order effect is that Azure’s backlog and Copilot adoption reduce earnings sensitivity to near-term macro noise, while the market is still anchoring on capex intensity and headline multiple compression; that mismatch typically creates the best entry points in dominant infra names. The shares likely need only a modest re-rating to recover meaningfully if investors start valuing the backlog as deferred revenue-like visibility rather than optionality.

The more interesting debate is not whether AI spend is large, but whether it is becoming self-funding fast enough. If Azure growth stays above the mid-30s and commercial margins hold, the current capex surge should transition from being a drag to a moat-expanding signal, because competitors without equivalent balance-sheet capacity will be forced to slow investment or accept lower returns. That creates a widening gap versus cloud peers and smaller software vendors whose AI claims are more easily copied and less monetizable.

Near term, the stock is still vulnerable to any evidence that AI revenue lags infrastructure buildout by even one quarter, especially if the next print shows another step-up in capex without a corresponding margin inflection. The contrarian risk is that consensus may be underestimating how much of the positive AI narrative is already in the stock via analyst enthusiasm, so the path higher could be slower than the earnings beat suggests. That said, the asymmetry still favors ownership because the downside is more likely to be a time correction than a thesis break unless Azure decelerates materially below the mid-30s for multiple quarters.

Key Decisions for Investors

• Add to MSFT on weakness into the next earnings window (April 29) with a 3-6 month horizon; risk/reward favors buying below the 200-day average if Azure growth holds >35%, as the market should re-rate from capex fear to backlog visibility.
• Pair trade: long MSFT / short a basket of lower-quality AI beneficiaries (software or cloud names without clear monetization) for a 6-12 month relative-value expression; thesis is that capital will concentrate in the few platforms with real AI distribution and balance-sheet firepower.
• Use call spreads in MSFT rather than outright stock if entry is pre-earnings; 6-9 month upside should be driven by multiple expansion and margin proof, while defined downside protects against a capex-led miss.
• If next quarter shows Azure growth slowing below the high-30s or capex rising without margin lift, trim 25-33% of the position and rotate into other mega-cap quality until the market recalibrates.
• Consider shorting high-multiple software names that depend on AI narrative but lack proprietary cloud distribution as a hedge against an eventual rotation into monetized AI platforms like MSFT.